The development of long-acting drug depots represents a significant advancement in pharmaceutical technology, offering ...

Amneal Pharmaceuticals and Shilpa Medicare have launched the new presentation of bortezomib, Boruzu, for subcutaneous or ...

Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced that the U.S. Food and Drug ...

ISLAMABAD: The Drug Regulatory Authority Pakistan (DRAP) has issued an immediate recall alert for a number of substandard ...

seven kgs of intoxicating powder, and over 300 injections have also been seized by the police; 44 buildings of individuals involved in drug trafficking have been demolished, and 49 individuals ...

Access to a webcast of the presentation will be available on the “Investors” page of Liquidia’s website at https://liquidia.com/investors/events-and-presentations. An archived, recorded version of the ...

PRINT enabled the creation of Liquidia's lead candidate, YUTREPIA (treprostinil) inhalation powder, an investigational drug for the treatment ... generic Treprostinil Injection for the treatment ...

Punjab Chief Minister Bhagwant Mann on Sunday called upon the people of the state to actively participate in the government’s crusade against drugs, Yudh Nasheyan Virudh, and help eradicate the menace ...

that its New Drug Application (NDA) resubmission for YUTREPIA™ (treprostinil) inhalation powder has been accepted. The treatment is aimed at patients with pulmonary arterial hypertension (PAH) and ...

Following the presentations, each poster will be available on the Publications page of Liquidia's website at https://liquidia.com/publications.